You have 9 free searches left this month | to do more

apalutamide

Apalutamide is a drug used to treat Prostate Cancer, Prostatic Neoplasms, Prostate Adenocarcinoma, and other conditions. Apalutamide is being actively studied in 42 studies and prior, has been studied in 9.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCM D Anderson Cancer CenterRahul Aggarwal
M.D. Anderson Cancer CenterDana Farber Cancer InstituteAnthony V. D'Amico, MD, PhD
Aragon Pharmaceuticals, Inc.Memorial Sloan Kettering Cancer CenterAristotelis Bamias
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • Apalutamide
  • (no location specified)
2021-08-02
Aug 2, 2021
R
Not yet recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • Apalutamide
  • Cetrelimab
  • San Francisco, California
    University of California, San Francisco
2021-10-05
Oct 5, 2021
U
Active, not recruiting
  • Prostate Adenocarcinoma
  • Apalutamide
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-09-17
Sep 17, 2021
U
Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
2020-11-15
Nov 15, 2020
K
Recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • Apalutamide
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Hospital
2020-12-06
Dec 6, 2020
C
Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
2021-08-03
Aug 3, 2021
I
Active, not recruiting
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
2021-05-14
May 14, 2021
W
Active, not recruiting
  • Prostate Cancer Metastatic
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +1 more
2021-08-26
Aug 26, 2021
C
Completed
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2021-03-24
Mar 24, 2021
J
Active, not recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • Beijing, China
  • +3 more
2021-10-07
Oct 7, 2021
J
Recruiting
  • Hepatic Impairment
  • Apalutamide
  • Orlando, Florida
  • +2 more
2021-10-07
Oct 7, 2021
U
Recruiting
  • Castration Levels of Testosterone
  • +3 more
  • Apalutamide
  • Stereotactic Body Radiation Therapy
  • San Francisco, California
    University of California, San Francisco
2021-08-26
Aug 26, 2021
E
Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
2020-08-13
Aug 13, 2020
N
Recruiting
  • Prostate Adenocarcinoma
  • Apalutamide
  • Quality-of-Life Assessment
  • Tucson, Arizona
  • +4 more
2021-09-11
Sep 11, 2021
J
Completed
  • Healthy
  • Apalutamide
  • Merksem, Belgium
    Clinical Pharmacology Unit
2020-08-07
Aug 7, 2020
M
Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-14
May 14, 2021
D
Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • La Jolla, California
  • +3 more
2021-09-01
Sep 1, 2021
J
Active, not recruiting
  • Salivary Gland Neoplasms
  • Apalutamide
  • GnRH Agonist
  • Chuo-Ku, Japan
  • +6 more
2021-10-07
Oct 7, 2021
C
Recruiting
  • Cancer of Prostate
  • Apalutamide
  • +4 more
  • Aalst, Belgium
  • +8 more
2021-08-04
Aug 4, 2021
S
Completed
  • Cancer of the Prostate
  • Apalutamide
  • Singapore, Singapore
    Department of Urology
2020-03-17
Mar 17, 2020
T
Withdrawn
  • Prostate Cancer
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
2020-02-25
Feb 25, 2020
D
Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
2021-09-21
Sep 21, 2021